Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan;17(2):77-80.
doi: 10.2217/fmb-2021-0250. Epub 2021 Dec 17.

Inflammation at the crossroads of Helicobacter pylori and COVID-19

Affiliations
Editorial

Inflammation at the crossroads of Helicobacter pylori and COVID-19

Ileana Gonzalez et al. Future Microbiol. 2022 Jan.
No abstract available

Keywords: COVID-19; Helicobacter pylori; SARS-CoV-2; inflammation.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

References

    1. The Lancet. COVID-19: a new lens for non-communicable diseases. Lancet 396(10252), 649 (2020). - PMC - PubMed
    1. Hooi JKY, Lai WY, Ng WK et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153(2), 420–429 (2017). - PubMed
    1. Balamtekin N, Artuk C, Arslan M et al. The effect of Helicobacter pylori on the presentation and clinical course of coronavirus disease 2019 infection. J. Pediatr. Gastroenterol. Nutr. 72(4), 511–513 (2021). - PMC - PubMed
    1. Zhang M, Feng C, Zhang X et al. Susceptibility factors of stomach for SARS-CoV-2 and treatment implication of mucosal protective agent in COVID-19. Front. Med. 7, 597967 (2021). - PMC - PubMed
    1. Kao CY, Sheu BS, Wu JJ. Helicobacter pylori infection: an overview of bacterial virulence factors and pathogenesis. Biomed. J. 39(1), 14–23 (2016). - PMC - PubMed

Publication types